iShares Biotechnology ETF (IBB)

"⚠️CHECK YOUR BATCH: Pfizer mRNA Shot Batch Number Starting with "E" = "EXTREME Death Risk"

96 of the top 100 deadliest batches start with “E”

According to the FDA's Gene Therapy Guidance, it takes 15 years to understand the long-term consequences of mRNA gene-transfer shots. " ⚠️CHECK YOUR BATCH: Pfizer mRNA Shot Batch Number Starting with "E" = "EXTREME Death Risk"

96 of the top 100 deadliest batches start with “E”

According to the FDA's Gene Therapy Guidance, it takes 15 years to understand the long-term consequences of mRNA gene-transfer shots. https://t.co/nKy3C9E2us pic.twitter.com/NLdxdpEQ2u— Nicolas Hulscher, MPH (@NicHulscher) April 6, 2026 $IBB

Medical Marijuana Biotech Tilray $TLRY Medical Strengthens Italian Market Presence with the Launch of Tilray Medical Italia and Expanded Medical Cannabis Portfolio
https://www.stocktitan.net/news/TLRY/tilray-medical-strengthens-italian-market-presence-with-the-launch-3ock834rbujj.html $IBB

The U.S. government’s cannabis rescheduling has opened doors for Tilray to launch a new medical division, leveraging its $150M global medical infrastructure $TLRY $IBB

https://x.com/stopvaccinating/status/1929372232356331665/photo/1 $IBB

https://x.com/stopvaccinating/status/1929372232356331665/photo/1 $IBB

I knew the Covid vaccine was dangerous, but after listening to this hearing- it’s so much worse than we thought.

We heard from top experts who have been censored- until now.

Here is what we know about the vaccine 🧵 pic.twitter.com/g4Osbb67XM— Anna Matson (@AnnaRMatson) May 22, 2025 $IBB

BREAKING
▶️There is strong scientific evidence that mRNA vaccines cause kidney injury
(And there are literally thousands (3,751) such scientific articles about adverse effects from COVID vaccines)
👉Only a criminal system would not make significant efforts to inform all patients,… pic.twitter.com/wovh5wX7Px— Denis Rancourt (@denisrancourt) May 6, 2025 $IBB

Not sure who needs to hear this, but pet vaccines are also dangerous.

Ever wonder why pets get cancer so often? pic.twitter.com/CvEBV8v8GD— Died Suddenly (@DiedSuddenly_) May 13, 2025 $IBB

pic.twitter.com/2gnFdjm34n— Sensei (@Cobra______Kai) May 11, 2025 $IBB

What they uncovered:

US taxpayer dollars funded gain-of-function research at the Wuhan lab.
This research likely created COVID-19.

Meanwhile, Fauci repeatedly denied this connection under oath to Congress. pic.twitter.com/oVPUush1kK— Karl Mehta (@karlmehta) May 2, 2025 $IBB

INVVY will Dip and all to $3.00 by end of day unfortunately, the NEXT BIG RUNNER Will Be TNNP)

#STOCKS #StockMarket #biotech #LABU #StockMarketCrash20 #STOCKSTOBUY #stockmarkets #STOCKCRASH Unfortunately ?? The STOCKS will Crash, the Markets will get Totally Blood Red ,SELL THIS IS UR FINAL WARNING OR LOSE ALL UR $$$$ ?? MONEY!!! Only 1 ETF u will make $$ is on #LABD

Price Target On The NASDAQ BioTech ETF Revealed

As certain market sectors stall out, the biotechnology sector burst through its 2017 highs. This breakout will trigger a continued squeeze even higher on the iShares NASDAQ BioTech ETF $IBB. At a current price of $118.81, investors should expect further upside to a $133.00 target in the next month. Once there, investors should expect a sharp pull back and potential high for 2018. As a swing trader, I am patiently waiting to short that pivot high at $133.00 for a pull back to $114.50.





Gareth Soloway
InTheMoneyStocks

3:1 share split effective

BlackRock (NYSE:BLK) announces that the Board of Trustees of iShares Trust has authorized a share split for iShares Nasdaq Biotechnology ETF (IBB).

The Board has approved a 3-for-1 split for the fund for shareholders of record as of the close of business on November 28, 2017, payable after the close of trading on November 30, 2017. The 3-for-1 split will lower the share price and increase the number of outstanding shares. The total value of shares outstanding is not affected by the split.

IBB on fire, here why: FDA Approves Futuristic New Cancer Therapy, To Cost $475,000, Sending Biotechs Surging http://www.zerohedge.com/news/2017-08-30/fda-approves-futuristic-new-cancer-drug-cost-475000-sending-biotechs-surging

FINALLY... It breaks out; for now anyway!

Actually the answer is Obama care is working with the participating according to the latest Yahoo Finance report. This means more uncertainty in the future and an uphill battle to repeal. This could go on for quite a while longer but like always, the health care trend is upwards in the long run.

Since more people R covered under Obamacare , would that be good for bio since bio was strong for yrs under Obama until election.

IBB LONG TERM is UP

See if the IBB can rip a little higher tomorrow. SPY watch volume very important in these complacent markets. imo Save the QQQ.

Nothing goes straight up. I am bullish on biotech but I expect some profit taking soon. Would be a buyer on any pullback.

Looks like Merck is leading the pack here

ARRY - speculative cancer company running

300 Breakout

Closed over $300. Welcome back!

2017 will be a record year for the IBB

It is pretty crazy to think a stock chart can predict an event but the biotechnology ETF $IBB looks to have done just that. Yesterday, the ETF that tracks biotechnology and pharma stocks slammed into a trend line that is found by connecting the recent highs (see the chart below). Any technical trader will tell you that a sharp pull back should occur. Out walked Donald Trump today to give his press conference. One of the first things he did is trash biotech/pharma stocks over drug prices. The $IBB (biotech ETF) collapsed.



The stock chart here predicted the price action perfectly. However, most investors ignore the stock charts and trade off of CNBC and other media hype. Start watching the stock charts and become a better trader.





The biotech ETF stock chart predicted the Donald Trump slam

why is not algo-rythem trading outlawed,its doing more harm than good for stable markets

Am looking to get back into IBB because the group willprobably bounce back strong with Trump's support of the industry. (unlike Hillary). Am watching and waiting until the dust settles.

Looks to be capitulation now or soon

IF this can hold support around $240...it might flip back for a nice short run, for those willing to take a chance on it. I am watching it closely.

luv to see hillarys tweets backfire on her lying azz,,,ibb $300+ soon

hillary again opens her corrupt mouth and crash,,this has gotten old,,such a joke this game is.wish i had funds to buy

This looked healthy yesterday. All about getting through $300-$303.

nice call huh,,shrts r f'ed $$$$

here we go,,scare tactic worked for shorts to cover a bit,now we break for $300 trend,,myop $$$$

***** IBB 1 HOUR CLOSES

***** IBB MONTHLY 3 LINE BREAK

***** IBB MONTHLY

***** IBB DAY

This Is A Major Concern For Investors $IBB

The iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) has bounced beautifully off of double bottom support at $240 on the daily chart. Today it traded as high as $254.70, just two days after hitting $240.00.

Investors are wondering if it is safe to buy the $IBB? The short answer is... no. This is why...

There is a major concern on the daily chart of the biotech ETF IBB. Notice the confirmed break down that took place when the IBB broke through the upsloping trend line. Once confirmed, a retrace into that trend line (like we are seeing today) is almost always a heavy shorting opportunity. That means the IBB may fall sharply as early as next week. If the IBB is falling hard, you can bet the market is dropping sharply. This should be a major concern to not only biotech investors but all investors in the stock market. Note the chart below...

Chart: https://verifiedinvesting.com/uploads/files/IBB06.29.2016.JPG

Risk ON !....Risk ON !....

This sector, along with banking and others, is collapsing.

Our beloved IBB :

We're starting to look good again.

rusty: typo error: Meant $4.00

Gogogo push past 287 into 288 lets get to 290 before 3

Now 290 before 3pm!! Go IBB

Show me the a green day before 230!!

Go for greeeeen!!!